Patients receiving standard-dose temozolomide therapy are at risk of Pneumocystis carinii pneumonia

Clin Oncol (R Coll Radiol). 2007 Oct;19(8):631-2. doi: 10.1016/j.clon.2007.06.003. Epub 2007 Jul 20.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adrenal Cortex Hormones / adverse effects
  • Antibiotic Prophylaxis
  • Antineoplastic Agents, Alkylating / adverse effects*
  • Antineoplastic Agents, Alkylating / therapeutic use
  • CD4 Lymphocyte Count
  • Dacarbazine / adverse effects
  • Dacarbazine / analogs & derivatives*
  • Dacarbazine / therapeutic use
  • Glioma / drug therapy
  • Humans
  • Male
  • Middle Aged
  • Pneumonia, Pneumocystis / diagnosis
  • Pneumonia, Pneumocystis / etiology*
  • Risk Assessment
  • Risk Factors
  • Temozolomide

Substances

  • Adrenal Cortex Hormones
  • Antineoplastic Agents, Alkylating
  • Dacarbazine
  • Temozolomide